Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris

 

The general recommendations developed in this guideline are based on the Living Cochrane review (https://pubmed.ncbi.nlm.nih.gov/35603936/). With new evidence and new results becoming available, the guideline development group will consider these and decide if and when an update is necessary. This will also be the case for the recommendations for specific clinical and comorbid situations.

 

 

Download entire guideline document in the latest version (2024):

Download
5800

Last updated
Changes
Download
Introduction, scoping, population and targeted users
09/2023
Editorial changes
Download
448
Disease severity and treatment goals
09/2023
No changes
Download
761
Methods and evidence section
09/2023
Editorial changes
Download
234
Main Recommendations and Decision Grid
09/2023
Deucravacitinib was added
Download
1006
Implementation slides
01/2024
New data added
Download
419
IFPA Guideline
09/2023
Editorial changes
Download
397

Last updated
Changes
Download
Acitretin
03/2023
No changes
Download
306
Ciclosporin
03/2023
Reference added
Download
248
Fumarates
03/2023
No changes
Download
123
Methotrexate
03/2023
New data added
Download
452
Adalimumab
03/2023
No changes
Download
212
Apremilast
03/2023
New data added
Download
257
Bimekizumab
09/2023
New data added
Download
183
Brodalumab
09/2023
New data added
Download
97
Certolizumab – Pegol
09/2023
No changes
Download
105
Deucravacitinib
03/2024
Editorial changes
Download
123
Etanercept
03/2023
No changes
Download
66
Guselkumab
03/2023
No changes
Download
175
Infliximab
03/2023
No changes
Download
78
Ixekizumab
09/2023
New data added
Download
139
Risankizumab
09/2023
New data added
Download
222
Secukinumab
09/2023
New data added
Download
154
Tildrakizumab
03/2023
No changes
Download
116
Ustekinumab
03/2023
No changes
Download
108
Biosimilars
09/2023
New data added
Download
93
Newly approved medications and treatments in the pipeline
10/2021
No changes
Download
216

Last updated
Changes
Download
Psoriatic arthritis
03/2023
New data added, recommendations changed
Download
337
Inflammatory bowel disease
10/2021
Recommendation concerning bimekizumab added
Download
133
Cancer
09/2023
New data added
Download
328
Depression
09/2023
New data added
Download
94
Diabetes Mellitus
09/2023
New data added, recommendations changed
Download
159
Heart disease
03/2023
New data added
Download
153
Kidney disease
03/2023
New data added
Download
84
Neurological diseases
09/2023
New data added
Download
93
Viral Hepatitis
01/2024
Chapter currently under review
Tuberculosis: Screening
09/2023
Editorial changes
Download
148
Tuberculosis: Treatment
09/2023
Editorial changes
Download
161
Wish for child / Pregnancy
10/2021
Time until pregnancy added for bimekizumab
Download
287
Vaccinations
03/2023
Completely new written
Download
213
Inmunogenicity
10/2021
No changes
Download
86

Last updated
Changes
Download
Methods Report
09/2023
Editorial changes
Download
197
Strength and limitations
09/2023
No changes
Download
68
Abbreviations
09/2023
Editorial changes
Download
29